糖尿病用ペンの世界市場2021年-2025年

◆英語タイトル:Global Diabetic Pens Market 2021-2025
◆商品コード:IRTNTR41174
◆発行会社(リサーチ会社):Technavio
◆発行日:2021年5月19日
◆ページ数:約120
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

テクナビオ社は、糖尿病用ペンの世界市場規模が2021年から2025年まで年平均8%以上成長し、36.5億ドルに達すると予測しています。本調査資料では世界の糖尿病用ペン市場について調査・分析し、エグゼクティブサマリー、市場状況、市場規模、ファイブフォース分析、製品別(再利用可能糖尿病用ペン、使い捨て糖尿病用ペン)分析、顧客状況、地域別状況、企業状況、企業分析など、以下の項目を掲載しています。
・エグゼクティブサマリー
・市場状況
・市場規模
・ファイブフォース分析
・糖尿病用ペンの世界市場規模:製品別(再利用可能糖尿病用ペン、使い捨て糖尿病用ペン)
・顧客状況
・地域別状況
・企業状況
・企業分析
【レポートの概要】

Global Diabetic Pens Market 2021-2025

Technavio has been monitoring the diabetic pens market and it is poised to grow by $ 3.65 billion during 2021-2025, progressing at a CAGR of over 8% during the forecast period. Our report on the diabetic pens market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of diabetes and the availability of Diabetes Self-Management Education Programs. In addition, the increasing prevalence of diabetes is anticipated to boost the growth of the market as well.

The diabetic pens market analysis includes the product segment and geographic landscape.
Technavio’s diabetic pens market is segmented as below:

By Product
• Reusable diabetic pens
• Disposable diabetic pens

By Geographical Landscape
• North America
• Europe
• Asia
• ROW

This study identifies the increasing demand for diabetic injection pens as one of the prime reasons driving the diabetic pens market growth during the next few years.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on diabetic pens market covers the following areas:
• Diabetic pens market sizing
• Diabetic pens market forecast
• Diabetic pens market industry analysis

Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading diabetic pens market vendors that include AstraZeneca Plc, Becton, Dickinson and Co., Biocon Ltd., Companion Medical Inc., Digital Medics Pvt. Ltd., Eli Lilly and Co., Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Novo Nordisk AS, and Sanofi SA. Also, the diabetic pens market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit – https://www.technavio.com/report/diabetic-pens-market-industry-analysis

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

【レポートの目次】

• Executive Summary
o Market overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 – 2025
• Five Forces Analysis
o Five Forces Summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Reusable diabetic pens – Market size and forecast 2020-2025
o Disposable diabetic pens – Market size and forecast 2020-2025
o Market opportunity by Product
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2020-2025
o Europe – Market size and forecast 2020-2025
o Asia – Market size and forecast 2020-2025
o ROW – Market size and forecast 2020-2025
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o AstraZeneca Plc
o Biocon Ltd.
o Companion Medical Inc.
o Digital Medics Pvt. Ltd.
o Eli Lilly and Co.
o Emperra GmbH E-Health Technologies
o Jiangsu Delfu medical device Co. Ltd.
o Novo Nordisk AS
o Sanofi SA
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2020 – 2025 ($ million)
• 13: Global market: Year-over-year growth 2020 – 2025 (%)
• 14: Five forces analysis 2020 & 2025
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2020
• 21: Product – Market share 2020-2025 (%)
• 22: Comparison by Product
• 23: Reusable diabetic pens – Market size and forecast 2020-2025 ($ million)
• 24: Reusable diabetic pens – Year-over-year growth 2020-2025 (%)
• 25: Disposable diabetic pens – Market size and forecast 2020-2025 ($ million)
• 26: Disposable diabetic pens – Year-over-year growth 2020-2025 (%)
• 27: Market opportunity by Product
• 28: Customer landscape
• 29: Market share By Geographical Landscape 2020-2025 (%)
• 30: Geographic comparison
• 31: North America – Market size and forecast 2020-2025 ($ million)
• 32: North America – Year-over-year growth 2020-2025 (%)
• 33: Europe – Market size and forecast 2020-2025 ($ million)
• 34: Europe – Year-over-year growth 2020-2025 (%)
• 35: Asia – Market size and forecast 2020-2025 ($ million)
• 36: Asia – Year-over-year growth 2020-2025 (%)
• 37: ROW – Market size and forecast 2020-2025 ($ million)
• 38: ROW – Year-over-year growth 2020-2025 (%)
• 39: Key leading countries
• 40: Market opportunity By Geographical Landscape ($ million)
• 41: North America – Market size and forecast 2020-2025 ($ million)
• 42: North America – Year-over-year growth 2020-2025 (%)
• 43: Europe – Market size and forecast 2020-2025 ($ million)
• 44: Europe – Year-over-year growth 2020-2025 (%)
• 45: Asia – Market size and forecast 2020-2025 ($ million)
• 46: Asia – Year-over-year growth 2020-2025 (%)
• 47: ROW – Market size and forecast 2020-2025 ($ million)
• 48: ROW – Year-over-year growth 2020-2025 (%)
• 49: Impact of drivers and challenges
• 50: Vendor landscape
• 51: Landscape disruption
• 52: Industry risks
• 53: Vendors covered
• 54: Market positioning of vendors
• 55: AstraZeneca Plc – Overview
• 56: AstraZeneca Plc – Product and service
• 57: AstraZeneca Plc – Key offerings
• 58: AstraZeneca Plc – Key customers
• 59: AstraZeneca Plc – Segment focus
• 60: Becton, Dickinson and Co. – Overview
• 61: Becton, Dickinson and Co. – Business segments
• 62: Becton, Dickinson and Co. – Key offerings
• 63: Becton, Dickinson and Co. – Key customers
• 64: Becton, Dickinson and Co. – Segment focus
• 65: Biocon Ltd. – Overview
• 66: Biocon Ltd. – Business segments
• 67: Biocon Ltd. – Key offerings
• 68: Biocon Ltd. – Key customers
• 69: Biocon Ltd. – Segment focus
• 70: Companion Medical Inc. – Overview
• 71: Companion Medical Inc. – Product and service
• 72: Companion Medical Inc. – Key offerings
• 73: Companion Medical Inc. – Key customers
• 74: Companion Medical Inc. – Segment focus
• 75: Digital Medics Pvt. Ltd. – Overview
• 76: Digital Medics Pvt. Ltd. – Product and service
• 77: Digital Medics Pvt. Ltd. – Key offerings
• 78: Digital Medics Pvt. Ltd. – Key customers
• 79: Digital Medics Pvt. Ltd. – Segment focus
• 80: Eli Lilly and Co. – Overview
• 81: Eli Lilly and Co. – Business segments
• 82: Eli Lilly and Co. – Key offerings
• 83: Eli Lilly and Co. – Key customers
• 84: Eli Lilly and Co. – Segment focus
• 85: Emperra GmbH E-Health Technologies – Overview
• 86: Emperra GmbH E-Health Technologies – Product and service
• 87: Emperra GmbH E-Health Technologies – Key offerings
• 88: Emperra GmbH E-Health Technologies – Key customers
• 89: Emperra GmbH E-Health Technologies – Segment focus
• 90: Jiangsu Delfu medical device Co. Ltd. – Overview
• 91: Jiangsu Delfu medical device Co. Ltd. – Product and service
• 92: Jiangsu Delfu medical device Co. Ltd. – Key offerings
• 93: Jiangsu Delfu medical device Co. Ltd. – Key customers
• 94: Jiangsu Delfu medical device Co. Ltd. – Segment focus
• 95: Novo Nordisk AS – Overview
• 96: Novo Nordisk AS – Business segments
• 97: Novo Nordisk AS – Key offerings
• 98: Novo Nordisk AS – Key customers
• 99: Novo Nordisk AS – Segment focus
• 100: Sanofi SA – Overview
• 101: Sanofi SA – Business segments
• 102: Sanofi SA – Key offerings
• 103: Sanofi SA – Key customers
• 104: Sanofi SA – Segment focus
• 105: Currency conversion rates for US$
• 106: Research Methodology
• 107: Validation techniques employed for market sizing
• 108: Information sources
• 109: List of abbreviations



【掲載企業】

AstraZeneca Plc, Becton, Dickinson and Co., Biocon Ltd., Companion Medical Inc., Digital Medics Pvt. Ltd. , Eli Lilly and Co., Emperra GmbH E-Health Technologies, Jiangsu Delfu medical device Co. Ltd., Novo Nordisk AS, Sanofi SA

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[糖尿病用ペンの世界市場2021年-2025年]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆